House of Commons (30) - Commons Chamber (11) / Written Statements (7) / Petitions (5) / Westminster Hall (3) / Ministerial Corrections (2) / General Committees (2)
(3 years, 9 months ago)
Written Statements(3 years, 9 months ago)
Written StatementsThe Cabinet Office has sought a repayable cash advance from the Contingencies Fund of £56,500,000.
The requirement has arisen due to increased costs relating to urgent expenditure, including that relating to the covid-19 response.
Parliamentary approval for additional resources of £56,500,000 will be sought in the supplementary estimate for the Cabinet Office. Pending that approval, urgent expenditure estimated at £56,500.000 will be met by repayable cash advances from the Contingencies Fund.
[HCWS691]
(3 years, 9 months ago)
Written StatementsI would like to provide an update on the whiplash reform programme.
The Government remain firmly committed to the implementation of the necessary and proportionate measures set out in part 1 of the Civil Liability Act 2018 and the associated increase to the small claims track limit for road traffic accident-related personal injury claims.
In my written ministerial statement of 21 April 2020, I spoke of the effect and impact that the covid-19 pandemic has had on the medical, legal and insurance sectors and the action that Government were taking to ease the difficulties caused by the outbreak. This included delaying the implementation of the whiplash reform programme to April 2021 in order to enable key sectors of this country’s business to focus on delivering their response to covid-19. This pause also allowed the Government to focus resource on the priority delivery of key justice services during the pandemic.
Despite the challenges the pandemic has presented, the MOJ continues to work with the Civil Procedure Rules Committee to finalise the supporting rules and pre-action protocol. In addition, the MOJ’s delivery partner the Motor Insurers’ Bureau continues to make excellent progress on the build of the official injury claim service.
I do however acknowledge the challenges experienced by all this year in the face of the pandemic. I said at the time of my April statement that the Government will continue to monitor developments in relation to the current pandemic and will, if necessary, make further announcements in regard to the implementation of these important reforms. So we have listened carefully to the concerns raised by stakeholders, in particular the need for as much notice as possible to take the necessary steps in anticipation of these reforms and to prepare their businesses for the changes to how small road traffic personal injury claims are managed. We understand the importance of industry preparedness and, after consideration, it is for that reason we have decided to allow an additional short period of time to further accommodate this. As such, we will implement the whiplash reform programme in May 2021.
This is a sensible and pragmatic approach to take in order to achieve successful and effective implementation of the whiplash reform programme. Delivering these reforms remains a key Government priority and we will continue to work with stakeholders to ensure that all are sufficiently prepared for the new measures upon implementation.
[HCWS693]
(3 years, 9 months ago)
Written StatementsThe report of the Independent Medicines and Medical Devices Safety Review (IMMDS Review) was published on 8 July last year. I would like first to sincerely thank Baroness Cumberlege and her team for their work on the review. I also pay tribute to the women and their families who bravely shared their experiences and brought these issues to light. Without their tireless efforts to have their voices heard, this review would not have been possible.
The overriding question investigated by the review is how the health and care system listens and responds to patient concerns raised by patients, and women in particular. We must not forget that the Cumberlege review, alongside other independent inquiries including the Paterson inquiry, was commissioned because women did not feel listened to or their concerns acknowledged—today is another step towards righting this.
On the Paterson inquiry, I would also like to provide a very brief update. Work on the Government response was temporarily paused last spring due to the first wave of the covid-19 pandemic. Efforts have since resumed at pace, and I can confirm today that I will announce and publish the Government’s initial response in Parliament shortly.
Returning to the IMMDS review, many of the report’s recommendations have already been discussed in detail during the Committee stage of the Medicines and Medical Devices Bill, and this has helped us to determine our future direction. We are very grateful to Members from both Houses who have worked with us on this.
I am today updating the House on the Government’s response to the report of the IMMDS review, taking each recommendation in turn.
Recommendation 1: The Government should immediately issue a fulsome apology on behalf of the healthcare system to the families affected by Primodos, sodium valproate and pelvic mesh.
In July, when I introduced this report to the House, I made an unreserved apology on behalf of the health and care system to those women, their children and their families for the time the system took to listen and respond. I assure those affected that the Government have listened, and will continue to listen.
Recommendation 2: The appointment of a Patient Safety Commissioner who would be an independent public leader with a statutory responsibility. The Commissioner would champion the value of listening to patients and promoting users’ perspectives in seeking improvements to patient safety around the use of medicines and medical devices.
The central recommendation in the report is for the establishment of an independent Patient Safety Commissioner. This recommendation has rightly ignited much interest and debate in both Houses, and the Government have listened carefully to the arguments made for a Commissioner, and how this might sit within the wider patient safety landscape.
Patient safety is a key priority for the healthcare system. In my role as Minister of State for patient safety, I often hear from and meet with people who have been affected by issues of patient safety. Their stories have common themes—of suffering avoidable harm, of not being listened to—and of a system that is then difficult to navigate when things go wrong. We want to make the NHS as safe as anywhere in the world, and we must retain an absolute focus on achieving this goal.
I can therefore confirm that the Government tabled an amendment to the Medicines and Medical Devices Bill before the Christmas recess to establish the role of an independent Patient Safety Commissioner, in line with Baroness Cumberlege’s second recommendation.
The Commissioner will act as an independent advocate for patients, and strengthen the ability of our health services to listen to the voice of patients. The Commissioner will be established as a statutory office holder, appointed by the Secretary of State for Health and Social Care, and will act independently on behalf of patients.
The Commissioner’s core duties will be to promote the safety of patients and the importance of the views of patients in relation to medicines and medical devices. To help in carrying out these duties, the Commissioner will have a number of powers and functions, including the ability to make reports and recommendations to the NHS and independent sector, and to request and share information with these bodies.
The Government look forward to working with Members of both Houses to ensure this new post acts as a beacon for listening and reflecting the safety concerns of patients, so that we can drive positive culture change in our healthcare system.
Recommendation 3: A new independent Redress Agency for those harmed by medicines and medical devices should be created based on models operating effectively in other countries. The Redress Agency will administer decisions using a non-adversarial process with determinations based on avoidable harm looking at systemic failings, rather than blaming individuals.
The Government have no current plans to establish a redress agency as set out in recommendation 3. The Government and industry have previously established redress schemes without the need for an additional agency.
Recommendation 4: Separate schemes should be set up for each intervention—HPTs, valproate and pelvic mesh—to meet the cost of providing additional care and support to those who have experienced avoidable harm and are eligible to claim.
Recommendation 4 on redress schemes for sodium valproate, mesh, and HPTs remains under consideration.
Recommendation 5: Networks of specialist centres should be set up to provide comprehensive treatment, care and advice for those affected by implanted mesh; and separately for those adversely affected by medications taken during pregnancy.
Good progress is being made on establishing specialist mesh services, which are the fifth recommendation in the report. NHS England is working with NHS hospitals to establish specialist mesh services which are currently planned to go live from the spring this year.
These services will bring together leading experts to provide multidisciplinary care and treatment for all women who have experienced complications due to vaginal or abdominal mesh procedures.
With a centre in every NHS region, these new services will ensure nationwide provision, and centres will work together to hone their expertise and share best practice.
We continue to consider the second part of recommendation 5, which is for specialist centres for those adversely affected by medicines in pregnancy.
Recommendation 6: The Medicines and Healthcare products Regulatory Agency (MHRA) needs substantial revision particularly in relation to adverse event reporting and medical device regulation. It needs to ensure that it engages more with patients and their outcomes. It needs to raise awareness of its public protection roles and to ensure that patients have an integral role in its work.
Patient safety is the MHRA’s top priority. The MHRA recognises that the major changes highlighted by the report, particularly recommendation 6, are very important.
The MHRA has already begun a substantial programme of work to improve how it involves patients in all aspects of its work, to reform systems for reporting adverse incidents with medicines and medical devices, and to strengthen the evidence base for its regulatory decisions.
Within the MHRA’s work to strengthen the evidence base, the safety of medicines in pregnancy is of utmost importance.
In the UK, three quarters of a million babies are born each year, and more than half of expectant mothers will need to take medicines when pregnant. We must ensure that women have high-quality, accessible information to be able to make informed decisions about their healthcare.
To that end, I would like to highlight two important developments of MHRA reform.
Firstly, the MHRA expert working group on optimising data on medicines used during pregnancy is today publishing its report which recommends ways in which healthcare data can be better collected and made available for analysis. This will enable the generation of better evidence on medicines used in pregnancy and will be vitally important when developing clear and consistent advice for women.
Second, the MHRA has established a safer medicines in pregnancy and breastfeeding consortium. This brings together 16 leading organisations from across the NHS, regulators, and key third sector and charitable organisations. Today, they are launching a strategy setting out how they will work to improve information on medicines for women who are thinking about becoming pregnant, are pregnant, or are breastfeeding.
Sodium Valproate
On sodium valproate, in response to concerns raised during the previous debate on the IMMDS review, I am pleased to announce that the National Director of Patient Safety has recently established a Valproate Safety Implementation Group.
This Valproate Safety Implementation Group will drive forward work to reduce harm from valproate through taking action to reduce the number of women prescribed valproate, and improving patient safety for women for whom there is no alternative medication, for example by increasing adherence to the Valproate Pregnancy Prevention Programme. The programme will ensure that every girl or woman knows about the risks of valproate in pregnancy, that where appropriate she is on effective contraception, and that she has a review by her specialist prescriber at a minimum once a year, when a risk acknowledgement form will be discussed and signed by both prescriber and woman herself. Importantly, the Valproate Safety Implementation Group will work with patients to understand how women can be supported to make informed decisions about their health care.
In addition, last week the MHRA published the conclusions of a safety review into antiepileptic drugs conducted by the Commission on Human Medicines. This will help clinicians identify safer alternatives to valproate for the treatment of epilepsy in women who may become pregnant.
I am also pleased to announce that the first data from the new Valproate Registry will become available later this month. The registry is being developed by the MHRA and NHS Digital, and will support work to monitor adherence to the Valproate Pregnancy Prevention Programme, and allow for long-term individual patient follow up.
Recommendation 7: A central patient-identifiable database should be created by collecting key details of the implantation of all devices at the time of the operation. This can then be linked to specifically created registers to research and audit the outcomes both in terms of the device safety and patient reported outcomes measures.
The seventh recommendation in Baroness Cumberlege’s report rightly reflects on the importance of collecting the right data for monitoring the safety of medical devices. We recognise the need for improved data collection and analysis for medical devices.
That is why the Government acted in June last year to amend the Medicines and Medical Devices Bill to create the power to establish a UK-wide medical device information system prior to the review report being published, as we recognised the need to deliver such an information system. This system will mean that in future, subject to regulations, we can routinely collect medical device, procedure and outcome data from all NHS and private provider organisations across the UK, ensuring that no patient in the UK falls through the gaps.
The Government are grateful to Members in both Houses, including Baroness Cumberlege, for their support for establishing a medical device information system.
Recommendation 8: Transparency of payments made to clinicians needs to improve. The register of the General Medical Council (GMC) should be expanded to include a list of financial and non-pecuniary interests for all doctors, as well as doctors’ particular clinical interests and their recognised and accredited specialisms. In addition, there should be mandatory reporting for the pharmaceutical and medical device industries of payments made to teaching hospitals, research institutions and individual clinicians.
The Government are considering recommendation 8, which is that doctors’ financial and non-pecuniary interests should be declared and publicly available.
Any publication of declarations of interest should cover all clinical decision-making staff, not just doctors: it would also need to be held where patients could most easily access and interpret the information, with appropriate governance arrangements. We will consider these issues in discussion with the GMC, other stakeholders and the patient reference group to ensure the views of patients are listened to and incorporated.
Recommendation 9: The Government should immediately set up a task force to implement this review’s recommendations. Its first task should be to set out a timeline for their implementation.
The Government have no plans to establish an independent taskforce to implement the report’s recommendations. A cross-system working group has already been set up, meeting regularly, to develop the Government’s detailed response to the report.
However, the Government recognise the need for effective patient engagement both to build trust, and ensure effective implementation. I am pleased to announce today that we are establishing a Patient Reference Group, which is part of Baroness Cumberlege’s ninth recommendation. The Patient Reference Group will ensure that patient voices are heard as we move forward towards a full response to the report.
Conclusion
The report of the IMMDS review powerfully demonstrates the importance of hearing the patient voice in patient safety matters. The actions outlined here demonstrate the Government’s commitment to learning from this report, and will support vital work already underway to hear the voice of the patient as part of the NHS Patient Safety Strategy. We currently plan to respond further to the report of the IMMDS review during 2021.
[HCWS692]
(3 years, 9 months ago)
Written StatementsLast week I announced further support to protect the most vulnerable through the national lockdown. This includes further efforts and funding to protect rough sleepers and ensure they are registered with a GP, where they are not already. I also confirmed that evictions will not be enforced by bailiffs until at least 21 February, except for in the most egregious situations. I have set out below the comprehensive set of measures the Government have put in place to protect tenants, while ensuring landlords have access to justice for the most serious cases.
Rough sleeping
Given the new variant of covid-19 that is driving infection rates and the Prime Minister’s announcement of a new national lockdown, it is clear we need to redouble our efforts to ensure that people who sleep rough, who we know are vulnerable to this disease, are kept as safe as possible and that we do everything we can to protect the NHS.
As a result, I am launching an additional £10 million fund, as part of the over £700 million deployed this year, to help ensure even more rough sleepers are safely accommodated and will be asking that this opportunity is actively used to make sure all rough sleepers are registered with a GP, and are factored into local area vaccination plans, in line with the Joint Committee on Vaccination and Immunisation (JCVI) prioritisation for covid-19 vaccinations. In due course, those vaccination efforts will be simpler and more successful where rough sleepers are in safe accommodation.
This Government are committed to ending rough sleeping and we have taken huge steps working with local authorities and their partners to protect rough sleepers during the pandemic. This work has not stopped, and in November we had supported around 33,000 people with nearly 10,000 in emergency accommodation and over 23,000 already moved on into longer-term accommodation.
This work has had a huge impact; intelligence from local authorities indicates that numbers on the streets have fallen significantly. A recent study published by The Lancet showed that because of this response 266 deaths were avoided during the first wave of the pandemic among England’s homeless population, as well as 21,092 infections, 1,164 hospital admissions and 338 admissions to intensive care units.
These efforts have been backed by significant Government support. We have given councils over £4.6 billion in unringfenced grants to help them to manage the impacts of covid-19, which we have been clear includes their work to support rough sleepers.
We have also been in close contact with councils to develop plans for the coming months, supported by the £266 million Next Steps Accommodation Programme which aims to ensure that as few people as possible return to the streets. This includes bringing forward 3,300 new homes this year for rough sleepers, leaving a national legacy of this Government’s support for these individuals.
In addition, to prepare for winter months, we launched a £10 million cold weather fund for all local authorities to bring forward covid-secure accommodation this winter and to keep vulnerable people safe from the cold. This is accompanied by a £2 million transformation fund for the voluntary sector, as well as comprehensive guidance on reopening night shelters more safely, where not doing so would endanger lives.
With the introduction of national restrictions in November, we asked all local authorities to update their plans for rough sleepers to make sure they had somewhere safe to go over the winter. We provided targeted support through the Protect Programme to support local authorities with higher numbers of rough sleepers to meet the specific challenges they faced. In total, we are spending over £700 million in 2020-21 on homelessness and rough sleeping.
Despite the success of ongoing interventions, we know there are some people on the streets who have not engaged with that support, or have lost accommodation provided to them, which is why I have asked local authorities to make further efforts to accommodate all rough sleepers again, even those who have previously refused help.
The Government have asked local areas to ensure that vulnerable groups will be able to access the vaccine, when they fall into one of the JCVI priority groups, and this should include people experiencing rough sleeping. Local authorities should work with their local health partners to ensure that—when they are prioritised—individuals experiencing homelessness are able to access the vaccine by other means if mainstream provision is unsuitable. This will help ensure that the wider health needs of people who sleep rough are addressed, supporting them now and for the future.
I encourage all relevant partners and local authorities to consider how they can best use the available support to protect the most vulnerable.
Ongoing protection for renters
Since the start of the pandemic, the Government have put in place unprecedented support to protect renters. Further legislation to extend protections for renters has come into force today, continuing to prevent bailiffs from attending residential premises to enforce a writ or warrant of possession except in the most egregious circumstances. This will ensure we continue to protect public health during the new period of national lockdown restrictions, at a time when the risk of virus transmission is very high, and to avoid placing additional burdens on the NHS and local authorities.
The measure contains some exemptions for the most serious cases. These exemptions are for:
cases where the court is satisfied that the claim is against trespassers who are persons unknown;
cases where the court is satisfied that the order for possession was made wholly or partly on the grounds of antisocial behaviour, nuisance or false statements, domestic abuse in social tenancies or substantial rent arrears equivalent to six month’s rent; or
where the property is unoccupied and the court is satisfied that the order for possession was made wholly or partly on the grounds of death of the tenant.
Many landlords have been compassionate and shown huge forbearance for tenants over this period. However, in order to ensure that the restrictions do not disproportionately impact landlords, some of whom rely on rental income for their livelihoods, we have amended the rent arrears exemption from the earlier regulations, to apply in cases where there are six months’ rent arrears or more. Recognising the need for landlords to be able to access justice in cases such as this, the Government have amended the rent arrears exemption to apply in cases where there are six months’ rent arrears or more.
This legislation will be in place for at least six weeks, when it will be reviewed and consideration taken to the latest public health data. The legislation applies to England only.
These continued restrictions on bailiff enforcement build on protections for renters announced last year, including six-month notice periods until at least the end of March for all but the most serious cases. This means that renters served notice today can stay in their homes until July 2021, with time to find alternative support or accommodation.
Courts will continue to remain open throughout the new period of national lockdown restrictions. The court rules and procedures introduced in September to respond to the pandemic remain in place and will be regularly reviewed. This includes the requirement for landlords to send the court information about the impact the pandemic has had on their tenant. The judiciary will continue to prioritise the most serious cases, such as antisocial behaviour or fraud.
In addition, the Government are piloting a new mediation service as part of the possession action process to support landlords and tenants to resolve disputes before a formal court hearing takes place. This new service will be free to use for tenants and landlords that agree to do so. We anticipate the pilot rolling out in February for six months. It will help more tenants at an early stage of the possession process, mitigating the risk of tenants becoming homeless and helping to sustain tenancies where possible.
We have taken action to prevent people getting into financial hardship by helping businesses to pay salaries, with the job retention scheme extended to the end of April, and boosted the welfare safety net by billions. This helps to ensure that tenants are able to pay their rent, minimising the impact on landlords. We strongly encourage all tenants to pay their rent and if they are having difficulty in doing so, they should have an early conversation with their landlord.
To further support landlords with buy to let mortgages, the mortgage holiday has been extended with applications open to 31 March 2021. Borrowers impacted by coronavirus that have not yet had a mortgage payment holiday will be entitled to a six-month holiday, and those that have already started a mortgage payment holiday will be able to top up to six months without this being recorded on their credit file.
Taken together, our package of protections for renters strikes the right balance between prioritising public health and supporting renters, while ensuring landlords can access and exercise their right to justice. This, along with the measures being announced today to step up the Government’s ongoing support for rough sleepers and ensure their wider health needs are addressed, will safeguard the most vulnerable people across England through the national lockdown.
[HCWS694]
(3 years, 9 months ago)
Written StatementsThe Government are committed to promoting fairness and transparency for homeowners and ensuring that consumers are protected from abuse and poor service.
Last week I announced the most significant set of reforms to how we hold property for at least 40 years and the beginning of even more fundamental change to English property law, through the widespread introduction of the commonhold tenure.
To deliver this, we will bring forward legislation in the upcoming session to set future ground rents to zero. This will be the first part of seminal two-part legislation to implement reforms in this Parliament.
Enfranchisement valuation and lease extensions
In 2017 the Government asked the Law Commission to review the legislation on leasehold enfranchisement, with the aim of making it easier, quicker and more cost-effective for leaseholders to buy their freehold or extend their lease.
The Law Commission have now completed this work and their findings are clear. Under the current system, too many leaseholders find the process for extending their lease or buying their freehold prohibitively expensive, too complex and lacking transparency. I am addressing this, addressing historic imbalance to ensure fairness for leaseholders, whilst taking account of the legitimate rights of freeholders. I will continue to ensure we meet this objective as we bring forward reforms.
The Government will reform the process of enfranchisement valuation leaseholders must follow to calculate the cost of extending their lease or buying their freehold. Taken together these measures could save leaseholders thousands of pounds, depending on the remaining term of their lease.
The Government will abolish marriage value, cap the treatment of ground rents at 0.1% of the freehold value and prescribe rates for the calculations at market value. The Government will also introduce an online calculator, further simplifying the process for leaseholds and ensuring standardisation and fairness for all those looking to enfranchise.
Existing discounts for improvements made by the leaseholder and for security of tenure will be retained, alongside a separate valuation methodology for low-value properties known as “section 9(1)”. Leaseholders will also be able to voluntarily agree to a restriction on future development of their property to avoid paying “development value”.
Leaseholders of houses can currently only extend their lease once at a “modern ground rent” for 50 years, compared to leaseholders of flats who can extend as often as they wish at a zero “peppercorn” ground rent for 90 years.
I am confirming that the Government will give leaseholders of all types of property the same right to extend their lease as often as they wish, at zero ground rent, for a term of 990 years. There will continue to be redevelopment breaks during the last 12 months of the original lease or the last five years of each period of 90 years of the extension, subject to existing safeguards and compensation.
We will also enable leaseholders, where they already have a long lease, to buy out the ground rent without the need to extend the term of the lease.
Commonhold
In 2017 the Government also asked the Law Commission to recommend reforms to reinvigorate commonhold as a workable alternative to leasehold, for both existing and new homes.
Having closely reviewed their report, I am confirming I will establish a new Commonhold Council as a partnership of industry, leaseholders and Government that will prepare homeowners and the market for the widespread take-up of commonhold. I will start this work immediately, including considering legislation. I know this will take time and close working with consumers and industry, and the Commonhold Council will be the critical first step of this.
Restricting future ground rents
Finally, ahead of legislating to restrict future ground rents to zero for future leases, I am also confirming that this policy now also applies to retirement properties. Restricting future ground rents to zero is a basic matter of fairness and including retirement properties will ensure that those who live in retirement housing benefit from the same reform as other leaseholders.
I do not see a compelling argument to exclude the elderly from this new protection, in fact, they deserve it more than most.
In recognition of the previous announcement of the ground rent exemption in June 2019, and wishing to mitigate potential impact on these developers, commencement of this provision will be deferred and come into force (for retirement properties) 12 months after Royal Assent.
This announcement is the beginning of a programme of historic leasehold and property reforms. This package is only part of Government’s response to the Law Commission’s reports. The Government will respond to the Law Commission’s remaining recommendations on enfranchisement, commonhold and right to manage in due course. We will translate these measures into law as soon as possible, starting with legislation to set future ground rents to zero in the upcoming Session. This will be the first part of major two-part legislation to implement leasehold and commonhold reforms in this Parliament.
It is my ambition that together these fundamentally enhance the fairness of English property rights and be seen in the future as landmark reforms to the way we own homes.
[HCWS695]
(3 years, 9 months ago)
Written StatementsLast week the Prime Minister announced that the Government had made the difficult but necessary decision to introduce a new national lockdown.
Both globally and domestically we are seeing significant increases in levels of coronavirus, including the emergence of worrying new strains. It is therefore imperative that we ensure we are doing all we can to protect travel, reduce the risk of imported infections, including from new variants, and protect our NHS while national lockdown and vaccinations take effect.
We already have strong safeguards in place, including a requirement for mandatory 10-day self-isolation for the vast majority of arrivals, and our travel corridors system remains critical in managing the risk of imported cases from high-risk countries. We also successfully launched the test to release scheme last month which provides passengers with the option to reduce self-isolation, through isolating for five days after they have left a destination not on the travel corridors list and then taking a test. Pre-departure testing does not remove the public health need for international arrivals travelling from non-exempt countries to isolate for 10 days or opt into test to release.
However, as a result of increasing instances of covid-19 around the world, including the emergence of new variants, we are now taking additional steps to add a further layer of protection to safeguard public health.
From 4 am on 15 January we will be introducing pre-departure testing requirements for all inbound passengers to England. Passengers arriving by ship, plane or train will have to take a test up to three days before departure and provide evidence of a negative result before they travel.
This will be an additional requirement that applies to all passengers, including those travelling from a travel corridor country, other than those on a very short list of exemptions. This extra layer of protection is in addition to existing self-isolation requirements.
We will establish the standards that tests must meet in regulations. This will include that the test must be of a diagnostic-standard test such as a polymerase chain reaction (PCR) test, and could in some cases include LAMP and lateral flow tests within set limits. We will provide clear guidance and advice to passengers regarding testing standards and capacity.
Guidance will be available to passengers and carriers on what to look for to assure tests and the results provided meet the standards required.
We will keep test standards and innovative testing technologies under review.
In addition, we will also set out the information passengers will need to have with them at check-in and the UK border to show they have had a qualifying negative test. This will include set data fields which test result certificates must include. All information on test requirements will be made available to passengers and transport operators through guidance on gov.uk.
The current advice for those across the UK remains that you must stay at home and not travel abroad unless it is for a permitted exempt reason. The requirements apply equally to visitors from other states and British nationals, and carriers may deny boarding if passengers are not in receipt of a qualifying negative test. British nationals that need consular assistance should contact the nearest consulate, embassy or high commission.
If British nationals test positive for covid-19 while abroad they should not travel and should follow the local relevant guidance on self-isolation.
Transport operators will be required to check that a passenger has proof of a negative test result before they board their flight, train or ferry, and may deny boarding where appropriate to reduce numbers of non-compliant individuals arriving in England. Border Force will also conduct further checks upon arrival.
If a passenger arrives in England without a pre-departure negative test result they will be fined. We will amend the international travel regulations so that fines, starting at £500, can be levied on non-compliant passengers. Operators will also be fined for transporting non-compliant passengers.
Passengers travelling to England from the common travel area (the United Kingdom, Ireland, Isle of Man, Jersey and Guernsey), will not be in scope of the regulations.
Children under the age of 11 will also not be required to complete pre-departure testing.
There will be a very restricted number of exemptions, including hauliers to allow the free flow of freight, and air, international rail and maritime crew.
Certain limited reasonable excuses for not undergoing testing will also be permitted, for example, lack of testing infrastructure in the departure country. This will apply to three overseas territories—St Helena, Ascension Island and the Falklands.
Arrivals from three additional countries will be considered to have a reasonable excuse not to comply due to lack of testing infrastructure. However, for these countries this will only apply for a specific, time limited window. This includes:
Antigua and Barbuda—until Thursday 21 January 04.00
St Lucia—until Thursday 21 January 04.00
Barbados—until Thursday 21 January 04.00
If passengers are arriving from one of the above three countries after the time limited window has ended, they will be required to meet all pre-departure testing requirements.
Further details on exemptions and reasonable excuses will be set out in regulations and in guidance. We will keep exemptions and reasonable excuses under regular review.
We will be making detailed guidance available to both passengers and transport operators to support the implementation of these changes.
Measures are likely to be in place until the end of the current lockdown, although a review will take place before the end of that period.
The Government recognise the continued challenges that the pandemic poses, both for individuals and for businesses.
We have worked closely with the international travel sector during the course of the pandemic and will continue to do so as we emerge from lockdown and are able to encourage people to travel again with confidence. We are also continuing to implement recommendations set out in the global travel taskforce report to support the safe recovery of international travel.
The delivery of a safe, effective vaccine is also the best way to protect the most vulnerable, save thousands of lives and support the removal of many of the restrictions and return to international travel. We are already making great progress, including having currently vaccinated more people than the rest of Europe combined.
In the immediate term our priority has to be on safeguarding public health and the NHS. With the addition of pre-departure testing requirements, our already robust system to protect against imported cases of coronavirus is further strengthened and will provide the greatest overall protection against the risk of transmission during travel to England and after arrival.
[HCWS696]